|1||NCT02298946||Completed||AMP-224, a PD-1 Inhibitor, in Combination With Stereotactic Body Radiation Therapy in People With Metastatic Colorectal Cancer||
||17||All||18 Years to 99 Years (Adult, Senior)||NCT02298946||150021
|November 21, 2014||July 13, 2016||April 7, 2017||November 24, 2014||October 19, 2017||
|2||NCT01440413||Active, not recruiting||Study of the Response to a Neoadjuvant Chemotherapy Based on the Antitumor Immune Response in Localized Breast Cancer||
||40||Female||18 Years and older (Adult, Senior)||NCT01440413||BREAST IMMUN
|BREAST IMMUN||December 2011||December 2018||December 2018||September 26, 2011||February 1, 2017||
† Study has passed its completion date and status has not been verified in more than two years.